High-dose buprenorphine therapy, provided under emergency department (ED) care, is safe and well tolerated in people with opioid use disorder experiencing opioid withdrawal symptoms, according to a NIDA study.
Researchers developed a wirelessly powered temporary pacemaker that breaks down in the body after use. The device can generate enough power to pace a human heart without causing damage or inflammation.
NIH is funding projects to identify ways of safely returning students and staff to in-person school in areas with vulnerable and underserved populations. part of NIH’s Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) program.
A diet higher in fatty fish helped frequent migraine sufferers reduce the frequency of headaches and intensity of pain compared to participants on a diet higher in vegetable-based fats and oils, according to a new study.
Adolescent marijuana use and binge drinking did not significantly change during the Covid-19 pandemic, despite record decreases in the substances’ perceived availability, according to a survey of 12th graders in the U.S. The NIDA-funded research was led by investigators at the University of Michigan, Ann Arbor.
In an NIAID-funded study, the immune response to the single-shot Janssen/Johnson & Johnson Covid-19 vaccine remained robust against variants.
An international coalition of eye researchers used machine learning to classify 25 of the most common types of uveitis, a collection of more than 30 diseases characterized by inflammation inside the eye.
New findings suggest there is no difference in cognitive outcomes at age 2 among children of healthy women and children of women with epilepsy who took antiseizure medication during pregnancy.
A team of researchers funded in part by NIAID and NCI created a vaccine that protects against a range of coronaviruses, including SARS-CoV-2.
New research shows that an innovative cardiac rehabilitation intervention started earlier and more custom-tailored to the individual improved physical function, frailty, quality-of-life and depression in hospitalized heart failure patients, compared to traditional rehab programs. These findings, supported by NIA, were published in the New England Journal of Medicine.